mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.006 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.007 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.008 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.008 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
-0.38 |
0.009 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |